Patient with non-cardioembolic ischemic stroke or high-risk transient ischemic attack. Part 1. Diagnosis

Non-cardioembolic stroke and transient ischemic attack (TIA) are heterogeneous conditions, some variants of which are associated with a high short-term and long-term risk of cardiovascular events. The article presents clinical portraits of patients in high and very high risk groups: 1) patients with extracranial atherosclerosis and severe stenosis/subocclusion/occlusion or CT signs of atherosclerotic plaque instability; 2) all patients with intracranial atherosclerosis, especially those with symptoms of hemodynamic compromise or multiple infarcts; 3) all patients with mobile/ulcerative atheroma of the aortic arch. For the timely identification of these subtypes, it is necessary to use clinical and radiological clues with necessary diagnostic search. In addition, the following patients with TIA may be at high or very high risk: those with an ABCD2 score of ≥4 points or an ABCD3-I score of ≥8 points; with TIA in the vertebrobasilar basin, "crescendo" or "limb shaking" type, orthostatic TIA, as well as patients with warning capsular and bridge syndromes. Assigning a patient to one of the considered categories requires the immediate administration of enhanced secondary prevention, which will be discussed in the second part of this article.

1. Diener HC, Hankey GJ. Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar. J Am Coll Cardiol. 2020 Apr 21;75(15):1804-18. doi: 10.1016/j.jacc.2019.12.072

2. Demin DA, Kulesh AA, Yanishevskiy SN, et al. Cryptogenic stroke. Part 3: atrial cardiopathy and silent atrial fibrillation. Meditsinskiy sovet = Medical Council. 2022;(21):8-18. doi: 10.21518/2079-701X2022-16-21-8-18 (In Russ.).

3. Kulesh AA. Difficult issues in the management of patients with atrial fibrillation: a neurologist's point of view. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(5):4-13. doi: 10.14412/2074-2711-2021-5-4-13 (In Russ.).

4. Yanishevsky SN. Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):116-20. doi: 10.14412/2074-2711-2018-3-116-120 (In Russ.).

5. Kolmos M, Christoffersen L, Kruuse C. Recurrent Ischemic Stroke – A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105935. doi: 10.1016/j.jstrokecerebrovasdis.2021.105935. Epub 2021 Jun 18.

6. Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24.

7. Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke. 2007 Nov;38(11):2979-84. doi: 10.1161/STROKEAHA.107.490896. Epub 2007 Sep 27.

8. Bejot Y, Bailly H, Durier J, Giroud M. Epidemiology of stroke in Europe and trends for the 21st century. Presse Med. 2016 Dec;45(12 Pt 2):e391-e398. doi: 10.1016/j.lpm.2016.10.003. Epub 2016 Nov 2.

9. De Weerd M, Greving JP, Hedblad B, et al. Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke. 2010 Jun;41(6):1294-7. doi: 10.1161/STROKEAHA.110.581058. Epub 2010 Apr 29.

10. Kulesh AA, Demin DA, Vinogradov OI. Pathogenetic mechanisms of ischemic stroke: from verification to secondary prevention. Consilium Medicum. 2021;23(11):792-9. doi: 10.26442/20751753.2021.11.201153 (In Russ.).

11. Josephson SA, Bryant SO, Mak HK, et al. Evaluation of carotid stenosis using CT angiography in the initial evaluation of stroke and TIA. Neurology. 2004 Aug 10;63(3):457-60. doi: 10.1212/01.wnl.0000135154.53953.2c

12. Tholen AT, de Monye C, Genders TS, et al. Suspected carotid artery stenosis: cost-effectiveness of CT angiography in work-up of patients with recent TIA or minor ischemic stroke. Radiology. 2010 Aug;256(2):585-97. doi: 10.1148/radiol.10091157

13. Saba L, Yuan C, Hatsukami TS, et al; Vessel Wall Imaging Study Group of the American Society of Neuroradiology. Carotid Artery Wall Imaging: Perspective and Guidelines from the ASNR Vessel Wall Imaging Study Group and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2018 Feb;39(2):E9-E31. doi: 10.3174/ajnr.A5488. Epub 2018 Jan 11.

14. Kamtchum-Tatuene J, Noubiap JJ, Wilman AH, et al. Prevalence of High-risk Plaques and Risk of Stroke in Patients With Asymptomatic Carotid Stenosis: A Meta-analysis. JAMA Neurol. 2020 Dec 1;77(12):1524-35. doi: 10.1001/jamaneurol.2020.2658

15. Murgia A, Erta M, Suri JS, et al. CT imaging features of carotid artery plaque vulnerability. Ann Transl Med. 2020 Oct;8(19):1261. doi: 10.21037/atm-2020-cass-13

16. Flaherty ML, Flemming KD, McClelland R, et al. Population-based study of symptomatic internal carotid artery occlusion: incidence and long-term follow-up. Stroke. 2004 Aug;35(8):e349-52. doi: 10.1161/01.STR.0000135024.54608.3f. Epub 2004 Jul 1.

17. Persoon S, Luitse MJ, de Borst GJ, et al. Symptomatic internal carotid artery occlusion: a long-term follow-up study. J Neurol Neurosurg Psychiatry. 2011 May;82(5):521-6. doi: 10.1136/jnnp.2010.208330. Epub 2010 Sep 30.

18. Larionov AA, Demin DA, Kulikova EA, et al. Transient ischemic attack “limb shaking” in a patient with subocclusion of the internal carotid artery. Angiologiya i sosudistaya khirurgiya. 2018;24(3):152-7 (In Russ.).

19. Mangla R, Kolar B, Almast J, Ekholm SE. Border zone infarcts: pathophysiologic and imaging characteristics. Radiographics. 2011 Sep-Oct;31(5):1201-14. doi: 10.1148/rg.315105014

20. Manrique-Zegarra M, Garcia-Pastor A, Castro-Reyes E, et al. CT angiography for diagnosis of carotid near-occlusion: a digital subtraction angiography validation study. Neuroradiology. 2022 Sep;64(9):1729-35. doi: 10.1007/s00234-022-02995-w. Epub 2022 Jun 22.

21. Banerjee C, Chimowitz MI. Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res. 2017 Feb 3;120(3):502-13. doi: 10.1161/CIRCRESAHA.116.308441

22. Psychogios M, Brehm A, Lopez-Cancio E, et al. European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease. Eur Stroke J. 2022 Sep;7(3):III-IV. doi: 10.1177/23969873221099715. Epub 2022 Jun 3.

23. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008 Aug;39(8):2396-9. doi: 10.1161/STROKEAHA.107.505776

24. Kim JT, Yoo SH, Kwon JH, et al. Subtyping of ischemic stroke based on vascular imaging: analysis of 1,167 acute, consecutive patients. J Clin Neurol. 2006 Dec;2(4):225-30. doi: 10.3988/jcn.2006.2.4.225. Epub 2006 Dec 20.

25. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995 Jan;26(1):14-20. doi: 10.1161/01.str.26.1.14

26. Hurford R, Wolters FJ, Li L, et al; Oxford Vascular Study Phenotyped Cohort. Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a populationbased cohort study. Lancet Neurol. 2020 May;19(5):413-21. doi: 10.1016/S1474-4422(20)30079-X

27. Bala F, Singh N, Moreau F, et al. Prevalence of Intracranial Atherosclerotic Disease in Patients with Low-Risk Transient or Persistent Neurologic Events. AJNR Am J Neuroradiol. 2022 Mar;43(3):376-80. doi: 10.3174/ajnr.A7429. Epub 2022 Feb 17.

28. Ritz K, Denswil NP, Stam OC, et al. Cause and mechanisms of intracranial atherosclerosis. Circulation. 2014 Oct 14;130(16):1407-14. doi: 10.1161/CIRCULATIONAHA.114.011147

29. Sun J, Feng XR, Feng PY, et al. HR-MRI findings of intracranial artery stenosis and distribution of atherosclerotic plaques caused by different etiologies. Neurol Sci. 2022 Sep;43(9):5421-30. doi: 10.1007/s10072-022-06132-6. Epub 2022 May 26.

30. Krasteva MP, Lau KK, Mordasini P, et al. Intracranial Atherosclerotic Stenoses: Pathophysiology, Epidemiology, Risk Factors and Current Therapy Options. Adv Ther. 2020 May;37(5):1829-65. doi: 10.1007/s12325-020-01291-4. Epub 2020 Apr 8.

31. Romano JG, Prabhakaran S, Nizam A, et al. MyRIAD Investigators. Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study. J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105504. doi: 10.1016/j.jstrokecerebrovasdis.2020.105504. Epub 2020 Dec 1.

32. Ha SH, Chang JY, Lee SH, et al. Mechanism of Stroke According to the Severity and Location of Atherosclerotic Middle Cerebral Artery Disease. J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105503. doi: 10.1016/j.jstrokecerebrovasdis.2020.105503. Epub 2020 Nov 30.

33. Qureshi AI, Caplan LR. Intracranial atherosclerosis. Lancet. 2014 Mar 15;383(9921):984-98. doi: 10.1016/S0140-6736(13)61088-0

34. Chen H, Hong H, Liu D, et al. Lesion patterns and mechanism of cerebral infarction caused by severe atherosclerotic intracranial internal carotid artery stenosis. J Neurol Sci. 2011 Aug 15;307(1-2):79-85. doi: 10.1016/j.jns.2011.05.012. Epub 2011 May 31.

35. El-Gammal TM, Bahnasy WS, Ragab OAA, Al-Malt AM. Cerebral border zone infarction: an etiological study. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):6. doi: 10.1186/s41983-018-0008-0. Epub 2018 Apr 25.

36. Yang WJ, Wasserman BA, Zheng L, et al. Understanding the Clinical Implications of Intracranial Arterial Calcification Using Brain CT and Vessel Wall Imaging. Front Neurol. 2021 Jul 15;12:619233. doi: 10.3389/fneur.2021.619233. eCollection 2021.

37. Song JW, Pavlou A, Xiao J, et al. Vessel Wall Magnetic Resonance Imaging Biomarkers of Symptomatic Intracranial Atherosclerosis: A Meta-Analysis. Stroke. 2021 Jan;52(1):193-202. doi: 10.1161/STROKEAHA.120.031480

38. Fischer U, Hsieh-Meister K, Kellner-Weldon F, et al. Symptomatic and asymptomatic intracranial atherosclerotic stenosis: 3 years' prospective study. J Neurol. 2020 Jun;267(6):1687-98. doi: 10.1007/s00415-020-09750-2. Epub 2020 Feb 25.

39. Prabhakaran S, Liebeskind DS, Cotsonis G, et al; MYRIAD Investigators. Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease. Stroke. 2021 Jun;52(6):1961-6. doi: 10.1161/STROKEAHA.120.032676. Epub 2021 Apr 19.

40. Yaghi S, Grory BM, Prabhakaran S, et al. Infarct Pattern, Perfusion Mismatch Thresholds, and Recurrent Cerebrovascular Events in Symptomatic Intracranial Stenosis. J Neuroimaging. 2019 Sep;29(5):640-4. doi: 10.1111/jon.12630. Epub 2019 May 21.

41. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994 Dec 1;331(22):1474-9. doi: 10.1056/NEJM199412013312202

42. Toyoda K, Yasaka M, Nagata S, Yamaguchi T. Aortogenic embolic stroke: a transesophageal echocardiographic approach. Stroke. 1992 Aug;23(8):1056-61. doi: 10.1161/01.str.23.8.1056

43. Cui X, Li Y, Liu J, et al. Aortic arch atheroma and the risk of stroke: a meta-analysis. J Evid Based Med. 2014 Aug;7(3):185-91. doi: 10.1111/jebm.12113

44. Nam HS, Han SW, Lee JY, et al. Association of aortic plaque with intracranial atherosclerosis in patients with stroke. Neurology. 2006 Oct 10;67(7):1184-8. doi: 10.1212/01.wnl.0000238511.72927.3c

45. Kim SJ, Ryoo S, Hwang J, et al. Characterization of the infarct pattern caused by vulnerable aortic arch atheroma: DWI and multidetector row CT study. Cerebrovasc Dis. 2012;33(6):549-57. doi: 10.1159/000338018. Epub 2012 Jun 8.

46. Amarenco P, Bogousslavsky J, Caplan LR, et al. The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis. 2013;36(1):1-5. doi: 10.1159/000352050. Epub 2013 Jul 30.

47. Viedma-Guiard E, Guidoux C, Amarenco P, Meseguer E. Aortic Sources of Embolism. Front Neurol. 2021 Jan 15;11:606663. doi: 10.3389/fneur.2020.606663. eCollection 2020.

48. Vizzardi E, Gelsomino S, D’Aloia A, Lorusso R. Aortic atheromas and stroke: review of literature. J Investig Med. 2013 Aug;61(6):956-66. doi: 10.2310/JIM.0b013e31829cbe04

49. Wehrum T, Dragonu I, Strecker C, et al. Aortic atheroma as a source of stroke – assessment of embolization risk using 3D CMR in stroke patients and controls. J Cardiovasc Magn Reson. 2017 Sep 6;19(1):67. doi: 10.1186/s12968-017-0379-x

50. Harloff A, Strecker C, Dudler P, et al. Retrograde embolism from the descending aorta: visualization by multidirectional 3D velocity mapping in cryptogenic stroke. Stroke. 2009 Apr;40(4):1505-8. doi: 10.1161/STROKEAHA.108.530030. Epub 2009 Jan 29.

51. French Study of Aortic Plaques in Stroke Group; Amarenco P, Cohen A, Hommel M, et al. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996 May 9;334(19):1216-21. doi: 10.1056/NEJM199605093341902

52. Guidoux C, Mazighi M, Lavallee P, et al. Aortic arch atheroma in transient ischemic attack patients. Atherosclerosis. 2013 Nov;231(1):124-8. doi: 10.1016/j.atherosclerosis.2013.08.025. Epub 2013 Sep 11.

53. Ntaios G, Pearce LA, Meseguer E, et al. Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial. Stroke. 2019 Nov;50(11):3184-90. doi: 10.1161/STROKEAHA.119.025813. Epub 2019 Sep 17.

54. Fischer U, Baumgartner A, Arnold M, et al. What is a minor stroke? Stroke. 2010 Apr;41(4):661-6. doi: 10.1161/STROKEAHA.109.572883. Epub 2010 Feb 25.

55. Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force; Levine SR, Khatri P, Broderick JP, et al. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke. 2013 Sep;44(9):2500-5. doi: 10.1161/STROKEAHA.113.000878. Epub 2013 Jul 11.

56. Wang Y, Wang Y, Zhao X, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013 Jul 4;369(1):11-9. doi: 10.1056/NEJMoa1215340. Epub 2013 Jun 26.

57. Johnston SC, Easton JD, Farrant M, et al; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19;379(3):215-25. doi: 10.1056/NEJMoa1800410. Epub 2018 May 16.

58. Johnston SC, Amarenco P, Denison H, et al; THALES Investigators. Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N Engl J Med. 2020 Jul 16;383(3):207-17. doi: 10.1056/NEJMoa1916870

59. Amarenco P, Labreuche J, Lavallee PC, et al. Does ABCD2 score below 4 allow more time to evaluate patients with a transient ischemic attack? Stroke. 2009 Sep;40(9):3091-5. doi: 10.1161/STROKEAHA.109.552042. Epub 2009 Jun 11.

60. Zhao M, Wang S, Zhang D, et al. Comparison of Stroke Prediction Accuracy of ABCD2 and ABCD3-I in Patients with Transient Ischemic Attack: A Meta-Analysis. J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2387-95. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.030. Epub 2017 Jun 21.

61. Pini R, Faggioli G, Gargiulo M, et al. The different scenarios of urgent carotid revascularization for crescendo and single transient ischemic attack. Vascular. 2019 Feb;27(1):51-9. doi: 10.1177/1708538118799225. Epub 2018 Sep 7.

62. Karkos CD, McMahon G, McCarthy MJ, et al. The value of urgent carotid surgery for crescendo transient ischemic attacks. J Vasc Surg. 2007 Jun;45(6):1148-54. doi: 10.1016/j.jvs.2007.02.005

63. He L, Xu R, Wang J, et al. Capsular warning syndrome: clinical analysis and treatment. BMC Neurol. 2019 Nov 13;19(1):285. doi: 10.1186/s12883-019-1522-0

64. Paul NL, Simoni M, Chandratheva A, Rothwell PM. Population-based study of capsular warning syndrome and prognosis after early recurrent TIA. Neurology. 2012 Sep 25;79(13):1356-62. doi: 10.1212/WNL.0b013e31826c1af8. Epub 2012 Sep 12.

65. Saposnik G, Noel de Tilly L, Caplan LR. Pontine warning syndrome. Arch Neurol. 2008 Oct;65(10):1375-7. doi: 10.1001/archneur.65.10.1375

66. Gulli G, Marquardt L, Rothwell PM, Markus HS. Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies. Stroke. 2013 Mar;44(3):598-604. doi: 10.1161/STROKEAHA.112.669929. Epub 2013 Feb 5.

67. Wangqin R, Wang X, Wang Y, et al. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial. Stroke Vasc Neurol. 2017 Jul 6;2(4):176-83. doi: 10.1136/svn-2017-000088. eCollection 2017 Dec.

68. Ois A, Gomis M, Rodriguez-Campello A, et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke. 2008 Jun;39(6):1717-21. doi: 10.1161/STROKEAHA.107.505438. Epub 2008 Mar 27.

69. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000 Dec 13;284(22):2901-6. doi: 10.1001/jama.284.22.2901